Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IMPACT
NCT05548452Phase 2Active, not recruiting
- Sponsor
- Virginia Commonwealth University
- Start
- Nov 2022
- Primary completion
- May 2027
- Modality
- Live Biotherapeutic Products
- Countries
- 1
01
Overview
A Phase 2 trial of Fecal Microbiota Transplantation capsules in alcohol-associated liver disease (ALD), Cirrhosis, alcohol use disorder (AUD), sponsored by Virginia Commonwealth University. Started Nov 2022; status: active, not recruiting.
02
Drugs
Fecal Microbiota Transplantation capsules
03
Conditions
alcohol-associated liver disease (ALD)Cirrhosisalcohol use disorder (AUD)
Beyond the preview
Go deeper on NCT05548452.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05548452.